AAAAAA

   
Results: 1-25 | 26-46
Results: 1-25/46
PULMONARY-EMBOLISM IN PATIENTS TAKING ESTROGEN-PROGESTAGEN ORAL-CONTRACEPTIVES
Authors: LAUQUE D MAZIERES J ROUZAUD P SIE P CHAMONTIN B CARRIE D HERMANT C TUBERY M CARLES P
Citation: D. Lauque et al., PULMONARY-EMBOLISM IN PATIENTS TAKING ESTROGEN-PROGESTAGEN ORAL-CONTRACEPTIVES, La Presse medicale, 27(31), 1998, pp. 1566-1569
CONTROL OF ORAL ANTICOAGULATION IN PATIENTS WITH THE ANTIPHOSPHOLIPIDSYNDROME - INFLUENCE OF THE LUPUS ANTICOAGULANT ON INTERNATIONAL NORMALIZED RATIO
Authors: ROBERT A LEQUERREC A DELAHOUSSE B CARON C HOUBOUYAN L BOUTIERE B HORELLOU MH REBER G SIE P
Citation: A. Robert et al., CONTROL OF ORAL ANTICOAGULATION IN PATIENTS WITH THE ANTIPHOSPHOLIPIDSYNDROME - INFLUENCE OF THE LUPUS ANTICOAGULANT ON INTERNATIONAL NORMALIZED RATIO, Thrombosis and haemostasis, 80(1), 1998, pp. 99-103
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: MISMETTI P LAPORTESIMITSIDIS S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H BONEU B
Citation: P. Mismetti et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 79(6), 1998, pp. 1162-1165
PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE, Thrombosis and haemostasis, 79(2), 1998, pp. 338-341
THE THROMBOMODULIN PROTEIN-C PROTEIN-S ANTICOAGULANT PATHWAY MODULATES THE THROMBOGENIC PROPERTIES OF THE NORMAL RESTING AND STIMULATED ENDOTHELIUM
Authors: CADROY Y DIQUELOU A DUPOUY D BOSSAVY J SAKARIASSEN K SIE P BONEU B
Citation: Y. Cadroy et al., THE THROMBOMODULIN PROTEIN-C PROTEIN-S ANTICOAGULANT PATHWAY MODULATES THE THROMBOGENIC PROPERTIES OF THE NORMAL RESTING AND STIMULATED ENDOTHELIUM, Arteriosclerosis, thrombosis, and vascular biology, 17(3), 1997, pp. 520-527
TISSUE FACTOR EXPRESSION BY HUMAN VASCULAR SMOOTH-MUSCLE CELLS IS RELATED TO PROLIFERATION - PDGF-INDUCED TF SYNTHESIS IS PREVENTED BY RAISING INTRACELLULAR CAMP
Authors: XUEREB JM SIE P BONEU B CONSTANS J
Citation: Jm. Xuereb et al., TISSUE FACTOR EXPRESSION BY HUMAN VASCULAR SMOOTH-MUSCLE CELLS IS RELATED TO PROLIFERATION - PDGF-INDUCED TF SYNTHESIS IS PREVENTED BY RAISING INTRACELLULAR CAMP, Thrombosis and haemostasis, 1997, pp. 827-827
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: BONEU B MISMETTI P LAPORTE S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H
Citation: B. Boneu et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 1997, pp. 1149-1149
COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS, Thrombosis and haemostasis, 1997, pp. 1160-1160
EFFECTS OF LYSOPHOSPHATIDIC ACID, A NOVEL LIPID MEDIATOR, ON CYTOSOLIC CA-MUSCLE CELLS IN CULTURE(+ AND PROLIFERATION OF HUMAN ADULT VASCULAR SMOOTH)
Authors: GENNERO I SIMON MF XUEREB JM GIROLAMI JP BASCANDS JL CHAP H BONEU B SIE P
Citation: I. Gennero et al., EFFECTS OF LYSOPHOSPHATIDIC ACID, A NOVEL LIPID MEDIATOR, ON CYTOSOLIC CA-MUSCLE CELLS IN CULTURE(+ AND PROLIFERATION OF HUMAN ADULT VASCULAR SMOOTH), Thrombosis and haemostasis, 1997, pp. 3030-3030
UP-REGULATION OF TISSUE FACTOR EXPRESSION BY PLATELET-DERIVED GROWTH-FACTOR IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS IN CULTURE - ROLE OF MITOGEN-ACTIVATED PROTEIN-KINASE AND EFFECTS OF INTRACELLULAR CYCLIC-AMP
Authors: XUEREB JM SIE P BONEU B CONSTANS J
Citation: Jm. Xuereb et al., UP-REGULATION OF TISSUE FACTOR EXPRESSION BY PLATELET-DERIVED GROWTH-FACTOR IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS IN CULTURE - ROLE OF MITOGEN-ACTIVATED PROTEIN-KINASE AND EFFECTS OF INTRACELLULAR CYCLIC-AMP, Thrombosis and haemostasis, 78(6), 1997, pp. 1520-1526
EVALUATION OF SENSITIVITY AND SPECIFICITY OF A STANDARDIZED PROCEDUREUSING DIFFERENT REAGENTS FOR THE DETECTION OF LUPUS ANTICOAGULANTS
Authors: GOUDEMAND J CARON C DEPROST D DERLON A BORG JY SAMPOL J SIE P
Citation: J. Goudemand et al., EVALUATION OF SENSITIVITY AND SPECIFICITY OF A STANDARDIZED PROCEDUREUSING DIFFERENT REAGENTS FOR THE DETECTION OF LUPUS ANTICOAGULANTS, Thrombosis and haemostasis, 77(2), 1997, pp. 336-342
ACUTE BASOPHILIC LEUKEMIA AND TRANSLOCATION T(X-6)(P11-Q23)
Authors: DASTUGUE N DUCHAYNE E KUHLEIN E RUBIE H DEMUR C AURICH J ROBERT A SIE P
Citation: N. Dastugue et al., ACUTE BASOPHILIC LEUKEMIA AND TRANSLOCATION T(X-6)(P11-Q23), British Journal of Haematology, 98(1), 1997, pp. 170-176
HEPARIN REVERSES THE PROCOAGULANT PROPERTIES OF STIMULATED ENDOTHELIAL-CELLS
Authors: CADROY Y GASPIN D DUPOUY D LORMEAU JC BONEU B SIE P
Citation: Y. Cadroy et al., HEPARIN REVERSES THE PROCOAGULANT PROPERTIES OF STIMULATED ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 75(1), 1996, pp. 190-195
ACQUIRED VON WILLEBRANDS DISEASE-ASSOCIAT ED WITH A MONOCLONAL GAMMOPATHY AND ANGIODYSPLASIA OF THE GUT - A RARE INDICATION TO HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
Authors: SAILLER L ECOIFFIER M CADROY Y COURET B SIE P MAZURIER C ARLETSUAU E POURRAT JP
Citation: L. Sailler et al., ACQUIRED VON WILLEBRANDS DISEASE-ASSOCIAT ED WITH A MONOCLONAL GAMMOPATHY AND ANGIODYSPLASIA OF THE GUT - A RARE INDICATION TO HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN, La Revue de medecine interne, 17(11), 1996, pp. 929-932
FREQUENCY OF RESISTANCE TO ACTIVATED PROTEIN-C DUE TO FACTOR-V MUTATION IN YOUNG-PATIENTS WITH ISCHEMIC STROKE
Authors: ALBUCHER JF GUIRAUDCHAUMEIL B CHOLLET F CADROY Y SIE P
Citation: Jf. Albucher et al., FREQUENCY OF RESISTANCE TO ACTIVATED PROTEIN-C DUE TO FACTOR-V MUTATION IN YOUNG-PATIENTS WITH ISCHEMIC STROKE, Stroke, 27(4), 1996, pp. 766-766
RESISTANCE TO ACTIVATED PROTEIN-C IN YOUNG-PATIENTS WITH ISCHEMIC STROKE
Authors: ALBUCHER JF CADROY Y SIE P GUIRAUDCHAUMEIL B CHOLLET F
Citation: Jf. Albucher et al., RESISTANCE TO ACTIVATED PROTEIN-C IN YOUNG-PATIENTS WITH ISCHEMIC STROKE, Neurology, 46(2), 1996, pp. 6106-6106
CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE (VOL 87, PG 3135, 1996)
Authors: CHARRIN C MAGAUD JP SEBBAN C FIERE D DASTUGUE N HUGUETRIGAL F ATTAL M SIE P LAI JL JOUET JP SIMON M ZANDECKI M GREGOIRE MJ WITZ F WITZ B BARIN C MORAINE C MUGNERET F FAVRE B RAYNAUD S GRATECOS N THYSS A AYRAUD N LAFAGE M AMOULET C SAINTY D MOZZICONACCI MJ STOPPA AM BERNARD P REIFFERS J BARANGER L BOASSON M IFRAH N VANDENAKKER J PERROT C BERTHEAS MF VASSELON C CALMARD P GUYOTAT D TALMANT P UETTWILLER F MALOLSEL F RUCH JV OBERLING F WEH HJ VERELLENDUMOULIN C LIBOUTON JM DELANNOY A FERRANT A MICHAUX JL DESANGLES F RIVIERE D PLUCHONRIVIERE E BERTHOU C PEDRON MF NOEL B LESPINASSE J MECUCCI C VANDENBERGHE H BERGER R POLSSONNIER M NOEL L GARDIN C TURELURE P VERHEST A GIOLLANT M DOSSANTOS E TOUMILHAC O RAMOND S DREYFUS F ZITTOUN R SMADJA N KRULIK M SCHOENWALD M VAUGLER GL LEBLOND V HURET JL GIRAUD C TANZER J ECLACHE V CAPODANO AM ZATTARACANNONI H LEONARD C TCHERNIA G
Citation: C. Charrin et al., CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE (VOL 87, PG 3135, 1996), Blood, 88(7), 1996, pp. 2818-2818
CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE
Authors: CHARRIN C MAGAUD JP SEBBAN C FIERE D DASTUGUE N HUGUETRIGAL F ATTAL M SIE P LAI JL JOUET JP SIMON M ZANDECKI M GREGOIRE MJ WITZ F WITZ B BARIN C MORAINE C MUGNERET F FAVRE B RAYNAUD S BAUDOIN F GRATECOS N THYSS A AYRAUD N LAFAGE M ARNOULET C SAINTY D MOZZICONACCI MJ STOPPA AM BERNARD P REIFFERS J VANDENAKKER J PERROT C BERTHEAS MF VASSELON C CALMARD P GUYOTAT D TALMANT P UETTWILLER F MALOISEL F RUCH JV OBERLING F WEH HJ VERELLENDUMOULIN C LIBOUTON JM DELANNOY A FERRANT A MICHAUX JL DESANGLES F RIVIERE D PLUCHONRIVIERE E BERTHOU C PEDRON MF NOEL B LESPINASSE J MECUCCI C VANDENBERGHE H BERGER R POISSONNIER M NOEL L GARDIN C TURELURE P VERHEST A GIOLLANT M DOSSANTOS E TOURNILHAC O RAMOND S DREYFUS F ZITTOUN R SMADJA N KRULIK M SCHOENWALD M VAUGIER GL LEBLOND V HURET JL GIRAUD C TANZER J ECLACHE V CAPODANO AM ZATTARACANNONI H LEONARD C TCHERNIA G
Citation: C. Charrin et al., CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE, Blood, 87(8), 1996, pp. 3135-3142
EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR (BFGF) AND FGF-RECEPTORSIN HUMAN LEUKEMIC-CELLS
Authors: ALLOUCHE M BAYARD F CLAMENS S FILLOLA G SIE P AMALRIC F
Citation: M. Allouche et al., EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR (BFGF) AND FGF-RECEPTORSIN HUMAN LEUKEMIC-CELLS, Leukemia, 9(1), 1995, pp. 77-86
PHARMACOKINETICS AND TOLERANCE OF THE NATURAL PENTASACCHARIDE (SR90107 ORG31540) WITH HIGH-AFFINITY TO ANTITHROMBIN-III IN MAN/
Authors: BONEU B NECCIARI J CARIOU R SIE P GABAIG AM KIEFFER G DICKINSON J LAMOND G MOELKER H MANT T MAGNANI H
Citation: B. Boneu et al., PHARMACOKINETICS AND TOLERANCE OF THE NATURAL PENTASACCHARIDE (SR90107 ORG31540) WITH HIGH-AFFINITY TO ANTITHROMBIN-III IN MAN/, Thrombosis and haemostasis, 74(6), 1995, pp. 1468-1473
RELATIONSHIP BETWEEN ENDOTHELIAL TISSUE FACTOR AND THROMBOGENESIS UNDER BLOOD-FLOW CONDITIONS
Authors: DIQUELOU A DUPOUY D GASPIN D CONSTANS J SIE P BONEU B SAKARIASSEN KS CADROY Y
Citation: A. Diquelou et al., RELATIONSHIP BETWEEN ENDOTHELIAL TISSUE FACTOR AND THROMBOGENESIS UNDER BLOOD-FLOW CONDITIONS, Thrombosis and haemostasis, 74(2), 1995, pp. 778-783
SUPPRESSION OF THROMBOMODULIN EXPRESSION ENHANCES THE THROMBOGENICITYOF IL1-STIMULATED ENDOTHELIAL-CELLS AT VENOUS AND ARTERIAL-WALL SHEARRATES
Authors: DIQUELOU A DUPOUY D SIE P SAKARIASSEN KS BONEAU B CADROY Y
Citation: A. Diquelou et al., SUPPRESSION OF THROMBOMODULIN EXPRESSION ENHANCES THE THROMBOGENICITYOF IL1-STIMULATED ENDOTHELIAL-CELLS AT VENOUS AND ARTERIAL-WALL SHEARRATES, Thrombosis and haemostasis, 73(6), 1995, pp. 899-899
ANTICOAGULANT AND NON-ANTICOAGULANT HEPARINS REVERSE THE PROCOAGULANTPROPERTIES OF STIMULATED ENDOTHELIAL-CELLS
Authors: CADROY Y GASPIN D DUPOUY D LORMEAU JC BONEU B SIE P
Citation: Y. Cadroy et al., ANTICOAGULANT AND NON-ANTICOAGULANT HEPARINS REVERSE THE PROCOAGULANTPROPERTIES OF STIMULATED ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 963-963
A NEW PATTERN OF BANDS IN SOUTHERN-BLOT ANALYSIS OF FACTOR-VIII GENE INVERSIONS
Authors: MAUGARD C MARTINEZ PA SCHVED JF CLAVESSENS S SIE P DEMAILLE J CLAUSTRES M
Citation: C. Maugard et al., A NEW PATTERN OF BANDS IN SOUTHERN-BLOT ANALYSIS OF FACTOR-VIII GENE INVERSIONS, Thrombosis and haemostasis, 73(6), 1995, pp. 1219-1219
EVALUATION OF APC RESISTANCE IN THE PLASMA OF PATIENTS WITH Q506 MUTATION OF FACTOR-V (FACTOR-V LEIDEN) AND TREATED BY ORAL ANTICOAGULANTS
Authors: CADROY Y SIE P ALHENCGELAS M AIACH M
Citation: Y. Cadroy et al., EVALUATION OF APC RESISTANCE IN THE PLASMA OF PATIENTS WITH Q506 MUTATION OF FACTOR-V (FACTOR-V LEIDEN) AND TREATED BY ORAL ANTICOAGULANTS, Thrombosis and haemostasis, 73(4), 1995, pp. 734-735
Risultati: 1-25 | 26-46